SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Life Science Innovation and the Restructuring of the Pharmaceutical Industry: Merger, Acquisition and Strategic Alliance Behaviour of Large Firms
0 references·12 citing·42 second hop
Life Science Innovation and the Restructuring of the Pharmaceutical Industry: Merger, Acquisition and Strategic Alliance Behaviour of Large Firms (2007)Life Science Innovation and the Restructu…Exploring the direct impact of environmental, social and governance (ESG) factors on organisational innovation output and institutional isomorphism: a study in the context of multinational life sciences organisations (2024)Exploring the direct impact o…International strategic alliances for collaborative product Innovation: An agent-based scenario analysis in biopharmaceutical industry (2023)International strategic allia…Strategic alliances for corporate sustainability innovation: The ‘how’ and ‘when’ of learning processes (2022)Strategic alliances for corpo…Open innovation practices for knowledge acquisition and their effects on innovation output (2019)Open innovation practices for…Understanding effectual decision-making in a science-based business: The case of Hart Biologicals (2018)Understanding effectual decis…Differentiation of innovation strategies based on pharmaceutical licensing agreements: Insight from Korean pharmaceutical firms (2018)Differentiation of innovation…The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance (2017)The moderating role of absorp…Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry (2016)Patent cliff and strategic sw…Inbound open innovation for pharmaceutical markets: a case study of an anti-diabetic drug in-licensing decision (2016)Inbound open innovation for p…Bridging a Pharma-Like Innovation Gap in Medical Nutrition (2014)Bridging a Pharma-Like Innova…Repairing the ‘Broken Middle’ of the Health Innovation Pathway (2013)Repairing the ‘Broken Middle’…OUTSOURCING, EXTERNAL COLLABORATION, AND INNOVATION AMONG U.S. FIRMS IN THE BIOPHARMACEUTICAL INDUSTRY (2009)OUTSOURCING, EXTERNAL COLLABO…Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Pasteur's Quadrant: Basic Science and Technological Innovation (2005)The sociology of expectations in science and technology (2006)Translational research in the science policy debate: a comparative analysis of documents (2017)Competitive Strategy: Techniques for Analyzing Industries and Competitors (1980)Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy (1986)Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy (1993)Theory of the firm: Managerial behavior, agency costs and ownership structure (1976)Firm Resources and Sustained Competitive Advantage (1991)Firm resources and sustained competitive advantage (2004)DENETİM LİTERATÜRÜNDE DÜNYA ÇAPINDA EĞİLİMLER: BİBLİYOMETRİK BİR ANALİZ (2023)EXPLAINING CHANGING PATTERNS OF INTERNATIONAL PRODUCTION: IN DEFENCE OF THE ECLECTIC THEORY (1979)Old technology meets new technology: complementarities, similarities, and alliance formation (2007)“Being There”: Proximity, Organization, and Culture in the Development and Adoption of Advanced Manufacturing Technologies* (2017)Business Models, Business Strategy and Innovation (2009)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)The Business Model: Recent Developments and Future Research (2011)Impact of China’s drug innovation policy on patent quantity and quality: Evidence from a representative chemical pharmaceutical enterprise (2025)The Theory of the Growth of the Firm (1995)Causation and Effectuation: Toward a Theoretical Shift from Economic Inevitability to Entrepreneurial Contingency (2001)Capitalism, Socialism and Democracy (2010)A ten-year cross-national examination of the dance between intuition and rationality in entrepreneurial processes (2021)Managing neolocalism outside the locale in real ale and craft beer entrepreneurship: The case of Ben Lui Brewery (2023)Organisational ambidexterity and sustainable value co-creation in a social enterprise: The case of Social Bite (2025)Architectural Innovation: The Reconfiguration of Existing Product Technologies and the Failure of Established Firms (1990)Exploration and Exploitation in Organizational Learning (1991)Open Innovation: The New Imperative for Creating and Profiting from Technology (2003)Alliance Network Diversity and Innovation Ambidexterity: The Differential Roles of Industrial Diversity, Geographical Diversity, and Functional Diversity (2020)Visitor-Sensing: Involving the Crowd in Cultural Heritage Organizations (2020)SDG-Oriented Supply Chains: Business Practices for Procurement and Distribution (2022)Qualitative Data Analysis: A Methods Sourcebook (1988)Case Study Research: Design and Methods (1991)Enhancing the contribution of higher education institutions to sustainable development research: A focus on post‐2015 SDGs (2024)Exploring and investigating the complementarity and multidimensionality of innovation for sustainability research: Past present and future (2024)Corporate entrepreneurship and the sustainable development goals: exploring the connection (2025)Interfirm cooperation and startup innovation in the biotechnology industry (1994)Sampling Knowledge: The Hermeneutics of Snowball Sampling in Qualitative Research (2008)The application of Fuzzy Delphi Method and Fuzzy AHP in lubricant regenerative technology selection (2009)Evaluation of Green Marketing Strategies by Considering Sustainability Criteria (2023)Determinants of Innovation Cooperation Performance: What Do We Know and What Should We Know? (2018)Direct and indirect effects of degree of interdisciplinarity on firms' innovation performance: The moderating role of firms' capabilities (2024)The pharmaceutical productivity gap – Incremental decline in R&D efficiency despite transient improvements (2024)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2019Open innovation practices for knowledge acquisition and their effects on innovation output63 cited
  • 2016Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry60 cited
  • 2022Strategic alliances for corporate sustainability innovation: The ‘how’ and ‘when’ of learning processes50 cited
  • 2017The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance42 cited
  • 2023International strategic alliances for collaborative product Innovation: An agent-based scenario analysis in biopharmaceutical industry24 cited
  • 2016Inbound open innovation for pharmaceutical markets: a case study of an anti-diabetic drug in-licensing decision24 cited
  • 2013Repairing the ‘Broken Middle’ of the Health Innovation Pathway17 cited
  • 2018Understanding effectual decision-making in a science-based business: The case of Hart Biologicals11 cited
  • 2009OUTSOURCING, EXTERNAL COLLABORATION, AND INNOVATION AMONG U.S. FIRMS IN THE BIOPHARMACEUTICAL INDUSTRY11 cited
  • 2014Bridging a Pharma-Like Innovation Gap in Medical Nutrition10 cited
  • 2024Exploring the direct impact of environmental, social and governance (ESG) factors on organisational innovation output and institutional isomorphism: a study in the context of multinational life sciences organisations5 cited
  • 2018Differentiation of innovation strategies based on pharmaceutical licensing agreements: Insight from Korean pharmaceutical firms

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

4 cited